Impact of Treatment Response on Risk of Serious Infections in Patients with Crohn ’s Disease: Secondary Analysis of the PYRAMID Registry

Traditional risk factors for serious infections with advanced therapies in patients with Crohn ’s disease (CD) have been assessed at baseline prior to starting therapy. We evaluated the impact of treatment response on the risk of serious infections in adalimumab-treated patients with CD through secondary analysis of the PYRAMID registry (NCT00524537).

Source: Clinical Gastroenterology and Hepatology - January 10, 2024 Category: Gastroenterology Authors: Dhruv Ahuja, Jiyu Luo, Yuchen Qi, Gaurav Syal, Brigid S. Boland, John Chang, Christopher Ma, Vipul Jairath, Ronghui Xu, Siddharth Singh Source Type: research